Stockreport

Roivant Sciences: Executing On Huge Buyback Program With More To Come [Seeking Alpha]

Immunovant, Inc.  (IMVT) 
PDF The company holds stakes in biotech companies worth billions, including Immunovant and Arbutus. Genevant and Arbutus offer potential litigation value of $5-10 billion [Read more]